{"ticker": {"uuid": "028894a2-fea3-4629-861d-03e119aeecfd", "symbol": "TMO", "name": "Thermo Fisher Scientific Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026", "summary": "WALTHAM, Mass., September 28, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the \"Investors\" section of our website, www.thermofisher.com under the subheading \"News, Events and Presentations\". You can access t", "url": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-28T12:00:00+00:00", "published_display": "28 Sep 2026 12:00", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.056769, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 89.4, "age_days": 0.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Results", "Quarterly Earnings"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?", "summary": "Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different. Thermo Fisher is benefiting from improving activity across life-sciences markets after a prolonged slowdown in pharmaceutical and biotech spending. Pfizer, meanwhile, is trying to rebuild growth around newer medicines as COVID revenue fades and generic and biosimilar competition pressures parts of its older portfolio. DON'T MISS: Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff? ", "url": "https://finance.yahoo.com/healthcare/articles/pfizer-vs-thermo-fisher-healthcare-225147227.html", "source_link": "https://finance.yahoo.com/healthcare/articles/pfizer-vs-thermo-fisher-healthcare-225147227.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-27T22:51:47+00:00", "published_display": "27 Sep 2026 22:51", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035187, "evidence_share": 50.5, "evidence_share_display": "50.5", "freshness_pct": 62.6, "age_days": 1.4, "influence_label": "Medium", "evidence_strength": 41, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Life Sciences", "Pharma", "Turnaround"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today", "summary": "For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. Another factor that can influence investors is FOMO, or the fear of missing out, especially with tech giants and popular consumer-facing stocks. What if you'd invested in Thermo Fisher Scientific (TMO) ten years ago? It may not have been easy to hold on to TMO for all that time, but if you did, how much would your investment be worth today? Thermo Fisher Scientific's Business In-Depth With tha", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-much-1000-investment-thermo-113002605.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/heres-much-1000-investment-thermo-113002605.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-25T11:30:02+00:00", "published_display": "25 Sep 2026 11:30", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.01148, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 26.6, "age_days": 3.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Consensus Estimate", "Earnings", "Earnings Estimate", "Pharma"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question", "summary": "Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return of 5.81%, building on a strong 90-day share price return of 31.55% as launches like the Gibco CHO-K1 Catalog Panel feed into a broader pipeline story. Over a longer horizon, the 1-year total shareholder return of 42.66% and 3-year total shareholder return of 34.82% indicate meaningful gains ", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-launches-101332022.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-launches-101332022.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-24T10:13:32+00:00", "published_display": "24 Sep 2026 10:13", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008939, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 18.4, "age_days": 4.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Balance Sheet", "Biologics", "Earnings", "Earnings Growth", "Healthcare", "Pharma"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific Launches Gibco\u2122 CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development", "summary": "New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: Gibco\u2122 CHO-K1 Catalog Panel Media and Feed Category: Basal and feed media for CHO-K1 cell culture Key benefit: Multiple ready-to-use media and feed options help developers rapidly identify high-performing combinations for CHO-K1 processes Additional benefits: Chemically defined, animal origin-fre", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-launches-gibco-123000578.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-launches-gibco-123000578.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-23T12:30:00+00:00", "published_display": "23 Sep 2026 12:30", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005558, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 13.5, "age_days": 5.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biologics", "Cell Culture", "Process Optimization"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue", "summary": "Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Content Screening (HCS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global market for High Content Screening (HCS) was valued at US$1.3 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030. This comprehensive report provides an in-depth a", "url": "https://finance.yahoo.com/healthcare/articles/capitalize-high-content-screening-disruption-081900540.html", "source_link": "https://finance.yahoo.com/healthcare/articles/capitalize-high-content-screening-disruption-081900540.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-22T08:19:00+00:00", "published_display": "22 Sep 2026 08:19", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.025343, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 38.1, "age_days": 7.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biomedical Research", "Cancer Research", "Drug Discovery", "Imaging Technologies", "Market Research Reports", "Personalized Medicine"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI", "summary": "Company Logo AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Throughput Screening (HTS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global market for High Throughput Screening (HTS) was estimated at US$42.9 Billion in 2024 and is projected to reach US$45.3 Billion by 2030, growing at a CAGR of 0.9% from 2024 to 2030. This comprehensive report provides an in-depth an", "url": "https://finance.yahoo.com/healthcare/articles/capitalize-high-throughput-screening-shift-081700866.html", "source_link": "https://finance.yahoo.com/healthcare/articles/capitalize-high-throughput-screening-shift-081700866.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-22T08:17:00+00:00", "published_display": "22 Sep 2026 08:17", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003874, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 9.0, "age_days": 7.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Automation", "Biotech", "Drug Discovery", "Market Research Reports", "Pharma", "Robotics"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "\u00bfEst\u00e1 la revisi\u00f3n al alza de las previsiones modificando el argumento de inversi\u00f3n de las acciones de Thermo Fisher (TMO)?", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-19T12:39:28+00:00", "published_display": "19 Sep 2026 12:39", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001982, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) is Positioned for Resurgence", "summary": "Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among AI-related investments, supported the rally. Technology, particularly semiconductors, led performance as demand for AI infrastructure surged. Despite macroeconomic uncertainties and interest rate infl", "url": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-tmo-positioned-143434079.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-tmo-positioned-143434079.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-18T14:34:34+00:00", "published_display": "18 Sep 2026 14:34", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Deteriorating financial comparison", "Operating growth"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001061, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.5, "age_days": 10.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Earnings Growth", "Investment Management", "Life Sciences", "Semiconductors", "Technology"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Three Analysts, Three Verdicts on Thermo Fisher: Here\u2019s Who the Numbers Favor", "summary": "Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor \u00a9TIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) has become the rare large-cap where three analysts studying the same company cannot agree on direction. On September 3, CLSA started coverage at Outperform with a $748 target. On September 9, UBS upgraded the stock to Buy from Neutral and lifted its target to $730 from $540, a move that came as the firm assum", "url": "https://finance.yahoo.com/markets/stocks/articles/three-analysts-three-verdicts-thermo-141149279.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/three-analysts-three-verdicts-thermo-141149279.html", "source_link_is_lookup": false, "source_name": "TIKR", "published_at": "2026-09-17T14:11:49+00:00", "published_display": "17 Sep 2026 14:11", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004228, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.7, "age_days": 11.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Biotech", "Earnings", "Net Income", "Pharma", "Price Target", "Upgrade Downgrade"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform?", "summary": "Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. Precure plans to integrate proteomic, genomic, and longitudinal clinical records into a single biomedical dataset to identify early disease signals. The collaboration positions Thermo Fisher Scientific's technology at the center of large scale healthcare data generation for research and clinical decision support. The Precure, LLC launch is important, but investors should weigh it alongside other Thermo Fisher Scientific risk signals. Our analysis turns ", "url": "https://finance.yahoo.com/healthcare/articles/why-thermo-fisher-scientific-tmo-131158873.html", "source_link": "https://finance.yahoo.com/healthcare/articles/why-thermo-fisher-scientific-tmo-131158873.html", "source_link_is_lookup": false, "source_name": "Simply Wall St.", "published_at": "2026-09-17T13:11:58+00:00", "published_display": "17 Sep 2026 13:11", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000812, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.7, "age_days": 11.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Collaboration", "Healthcare", "Research"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Sees Stronger Demand, Calls 2026 an \u2018Outstanding Year\u2019", "summary": "Key Points Interested in Thermo Fisher Scientific Inc.? Here are five stocks we like better. Thermo Fisher raised its outlook after returning to 5% organic growth in the second quarter, with adjusted EPS up 13%. CEO Marc Casper expects about 4% organic growth in 2026 and called it an \"outstanding year,\" citing orders running ahead of revenue. Pharma and biotech demand is strengthening as customers invest in drug-development pipelines, AI, and emerging therapies. Recovering biotech funding, mergers and acquisitions, and IPO activity are also supporting spending across clinical research, laborat", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-sees-stronger-demand-100208200.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-sees-stronger-demand-100208200.html", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-17T10:02:08+00:00", "published_display": "17 Sep 2026 10:02", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Guidance raised"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.024869, "evidence_share": 35.7, "evidence_share_display": "35.7", "freshness_pct": 19.2, "age_days": 11.9, "influence_label": "Medium", "evidence_strength": 38, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Clinical Research", "Earnings", "Earnings Per Share", "Growth Rate"], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "Thermo Fisher CEO Says AI Will Drive More Pharma Spending \u2014 Sees 7% Organic Growth By 2028", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-ceo-says-ai-171619596.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-ceo-says-ai-171619596.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-15T17:16:19+00:00", "published_display": "15 Sep 2026 17:16", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000555, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.9, "age_days": 13.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear", "summary": "Pioneering initiative will generate data at the frontier of healthcare to help transform early biological signals into new opportunities for prevention, diagnosis and treatment ROCHESTER, Minn. and WALTHAM, Mass., Sept. 15, 2026 /PRNewswire/ -- Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.Mayo Clinic Precure, LLC will create one of the world's leading biomedical d", "url": "https://finance.yahoo.com/healthcare/articles/mayo-clinic-thermo-fisher-scientific-120000321.html", "source_link": "https://finance.yahoo.com/healthcare/articles/mayo-clinic-thermo-fisher-scientific-120000321.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-15T12:00:00+00:00", "published_display": "15 Sep 2026 12:00", "source_kind": "press_release", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000447, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.8, "age_days": 13.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Data Analytics", "Diagnostics", "Healthcare Innovation", "Therapeutics"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "\u00bfEst\u00e1 Thermo Fisher Scientific (TMO) Cara Tras Lanzar Multiskan Ease?", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-15T07:00:00+00:00", "published_display": "15 Sep 2026 07:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000478, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.8, "age_days": 14.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Analysts See Thermo Fisher at $748 Here\u2019s Where the Stock Could Go", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOakd2T3NOd3BXVFhnd25ENHhkcDRJYXdEbTJUWi1GR2FEU0ZwRmFXZ0pzQUdmblFrQkU5TnBMek9RSmI2bGUyQTJKNmZHM0tVRjRGbVYxdER4Mkc2eDlNOFZZMm5QMWlBbk1NRXBKLTcyTE8xREYxZ2VsSkZoMUZIeXNvMEV6NlNHbU96N1h0X3plOXE1RXhXQkd5TDc4eEFKbUZzTm1EMUFhUQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOakd2T3NOd3BXVFhnd25ENHhkcDRJYXdEbTJUWi1GR2FEU0ZwRmFXZ0pzQUdmblFrQkU5TnBMek9RSmI2bGUyQTJKNmZHM0tVRjRGbVYxdER4Mkc2eDlNOFZZMm5QMWlBbk1NRXBKLTcyTE8xREYxZ2VsSkZoMUZIeXNvMEV6NlNHbU96N1h0X3plOXE1RXhXQkd5TDc4eEFKbUZzTm1EMUFhUQ?oc=5", "source_link_is_lookup": false, "source_name": "tikr.com", "published_at": "2026-09-11T15:45:00+00:00", "published_display": "11 Sep 2026 15:45", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000136, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says", "summary": "Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-danaher-could-log-175546656.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-danaher-could-log-175546656.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-09-09T17:55:46+00:00", "published_display": "09 Sep 2026 17:55", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006976, "evidence_share": 10.0, "evidence_share_display": "10", "freshness_pct": 6.6, "age_days": 19.6, "influence_label": "Low", "evidence_strength": 32, "duplicate_count": 1, "topics": [], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls", "summary": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: UBS upgraded Thermo Fisher(TMO) to Buy from Neutral with a price target of $730, up from $540, after a transfer in analyst coverage. Thermo Fisher is positioned for a durable return to 5%-6%-plus organic growth in 2027, supported by improving pharma/biotech funding, bioprocessing demand, reshoring, AI-driven R&D investment, share", "url": "https://finance.yahoo.com/markets/stocks/articles/uber-initiated-thermo-fisher-upgraded-135116768.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/uber-initiated-thermo-fisher-upgraded-135116768.html", "source_link_is_lookup": false, "source_name": "The Fly", "published_at": "2026-09-09T13:51:16+00:00", "published_display": "09 Sep 2026 13:51", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "positive", "sentiment_pct": 56, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000934, "evidence_share": 1.3, "evidence_share_display": "1.3", "freshness_pct": 1.0, "age_days": 19.7, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": ["Biotech", "Construction Materials", "Pharma", "Price Target", "Revenue Growth"], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ubs-upgrades-thermo-fisher-scientific-132027711.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ubs-upgrades-thermo-fisher-scientific-132027711.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-09-09T13:20:27+00:00", "published_display": "09 Sep 2026 13:20", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001711, "evidence_share": 2.5, "evidence_share_display": "2.5", "freshness_pct": 1.0, "age_days": 19.7, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "Should You Continue to Hold TMO Stock in Your Portfolio?", "summary": "Thermo Fisher Scientific Inc.'s TMO growth continues to benefit from a broader pickup in customer activity. The company is using acquisitions to move deeper into some of the more attractive corners of the life sciences market while strengthening ties with customers. At the same time, the company is improving its debt position while continuing to return cash to shareholders. Yet, a challenging macroeconomic environment and intense competition could weigh on Thermo Fisher's results. In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 6.7% against the 8.2% decline of the in", "url": "https://finance.yahoo.com/markets/stocks/articles/continue-hold-tmo-stock-portfolio-143500428.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/continue-hold-tmo-stock-portfolio-143500428.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-04T14:35:00+00:00", "published_display": "04 Sep 2026 14:35", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive market reaction", "Large positive market reaction"], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005187, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 8.7, "age_days": 24.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Debt", "Earnings", "Earnings Growth", "Earnings Per Share"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Las acciones de Thermo Fisher Scientific (TMO) parecen estar cerca de su valor razonable tras una subida del 24 %", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-02T09:47:20+00:00", "published_display": "02 Sep 2026 09:47", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 6e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 26.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "TMO Stock Could Gain Following the Launch of EMPAD G2 Detector", "summary": "Thermo Fisher Scientific Inc. TMO recently unveiled the Thermo Scientific EMPAD G2 detector to help researchers analyze materials in unprecedented detail. This development is expected to bolster the company's Analytical Instruments segment. TMO Stock Outlook Following the News After the announcement, TMO shares dipped slightly by 0.8% last Thursday. On a positive note, Thermo Fisher has steadily ramped up R&D investments in recent years, fueling new product launches and enhancing its portfolio. We expect the latest development to improve investor sentiment toward TMO stock and support its upwa", "url": "https://finance.yahoo.com/healthcare/articles/tmo-stock-could-gain-following-182900842.html", "source_link": "https://finance.yahoo.com/healthcare/articles/tmo-stock-could-gain-following-182900842.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-01T18:29:00+00:00", "published_display": "01 Sep 2026 18:29", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 54, "tone_signals": ["Positive financial language"], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006853, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.5, "age_days": 27.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Advanced Materials", "Earnings", "Earnings Growth", "Energy", "Medical", "Semiconductors"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026", "summary": "WALTHAM, Mass., September 01, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET). You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-present-morgan-120000343.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-present-morgan-120000343.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-01T12:00:00+00:00", "published_display": "01 Sep 2026 12:00", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001409, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.1, "age_days": 27.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Healthcare"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis", "summary": "Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced research and data intensive science through 56 AI infrastructure stocks.NYSE:TMO Earnings & Revenue Growth a", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-unveils-230701731.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-unveils-230701731.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-31T23:07:01+00:00", "published_display": "31 Aug 2026 23:07", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001928, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.0, "age_days": 28.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Life Sciences", "Mass Spectrometry", "Microscopy"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Is Up 23% in a Year. Is It Too Late to Buy at $622?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORXlGYnVfcmI3eVhjd2h1d2dEQURURU1RclVJVnE2RlVuNUhuUWxnZ0UxSFlTNFJodGZjVHNiSHpYMVR4LWYxMElidDJBUjlaNjlNMjE5R1hHV2J3UlFXYUdwOFQwYjBIaU9taHJhY3FZN0pTcXExaTNRX2ZRVVVjNWloLVBiS21hX1NqWnIwRDRkU20w?oc=5", "source_link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORXlGYnVfcmI3eVhjd2h1d2dEQURURU1RclVJVnE2RlVuNUhuUWxnZ0UxSFlTNFJodGZjVHNiSHpYMVR4LWYxMElidDJBUjlaNjlNMjE5R1hHV2J3UlFXYUdwOFQwYjBIaU9taHJhY3FZN0pTcXExaTNRX2ZRVVVjNWloLVBiS21hX1NqWnIwRDRkU20w?oc=5", "source_link_is_lookup": false, "source_name": "TIKR.com", "published_at": "2026-08-30T18:50:14+00:00", "published_display": "30 Aug 2026 18:50", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 29.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}], "by_tier": {"direct": [{"title": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026", "summary": "WALTHAM, Mass., September 28, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the \"Investors\" section of our website, www.thermofisher.com under the subheading \"News, Events and Presentations\". You can access t", "url": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-28T12:00:00+00:00", "published_display": "28 Sep 2026 12:00", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TN8.DU", "provider_symbols": ["TMO.US", "TN8.DU"], "target_provider_symbol": "TN8.DU", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "e18fe4ae8228c0620b53971c4f3f3d9fb7de5f9850f305a76e071ec9adc35d2d", "target_scope": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026 WALTHAM, Mass., September 28, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.07, "relevance_score": 0.72, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.056769, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 89.4, "age_days": 0.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Results", "Quarterly Earnings"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?", "summary": "Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different. Thermo Fisher is benefiting from improving activity across life-sciences markets after a prolonged slowdown in pharmaceutical and biotech spending. Pfizer, meanwhile, is trying to rebuild growth around newer medicines as COVID revenue fades and generic and biosimilar competition pressures parts of its older portfolio. DON'T MISS: Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff? ", "url": "https://finance.yahoo.com/healthcare/articles/pfizer-vs-thermo-fisher-healthcare-225147227.html", "source_link": "https://finance.yahoo.com/healthcare/articles/pfizer-vs-thermo-fisher-healthcare-225147227.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-27T22:51:47+00:00", "published_display": "27 Sep 2026 22:51", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["PFE.DU", "PFE.MU", "PFE.US", "TMO.US"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "0ff257846afcf048d95f896e6edf1b5a6954a7113b73c486c561df4cfdef4ade", "target_scope": "Thermo Fisher: Which Healthcare Turnaround has More Upside? Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, Thermo Fisher is benefiting from improving activity across life-sciences markets after a prolonged slowdown in pharmaceutical and biotech spending.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.521, "provider_directional_mass": 0.212, "relevance_score": 0.72, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035187, "evidence_share": 50.5, "evidence_share_display": "50.5", "freshness_pct": 62.6, "age_days": 1.4, "influence_label": "Medium", "evidence_strength": 41, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Life Sciences", "Pharma", "Turnaround"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today", "summary": "For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. Another factor that can influence investors is FOMO, or the fear of missing out, especially with tech giants and popular consumer-facing stocks. What if you'd invested in Thermo Fisher Scientific (TMO) ten years ago? It may not have been easy to hold on to TMO for all that time, but if you did, how much would your investment be worth today? Thermo Fisher Scientific's Business In-Depth With tha", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-much-1000-investment-thermo-113002605.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/heres-much-1000-investment-thermo-113002605.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-25T11:30:02+00:00", "published_display": "25 Sep 2026 11:30", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.MX", "provider_symbols": ["TMO.ARCHIVE", "TMO.MX", "TMO.US", "TMOS34.SA"], "target_provider_symbol": "TMO.MX", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "5950ca4993133ab3abf4503404e5c656d845d2d534e0ce462b57d8aa16e8ee26", "target_scope": "Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today What if you'd invested in Thermo Fisher Scientific (TMO) ten years ago? but It may not have been easy to hold on to TMO for all that time, Thermo Fisher Scientific's Business In-Depth With tha", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.164, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.01148, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 26.6, "age_days": 3.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Consensus Estimate", "Earnings", "Earnings Estimate", "Pharma"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question", "summary": "Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return of 5.81%, building on a strong 90-day share price return of 31.55% as launches like the Gibco CHO-K1 Catalog Panel feed into a broader pipeline story. Over a longer horizon, the 1-year total shareholder return of 42.66% and 3-year total shareholder return of 34.82% indicate meaningful gains ", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-launches-101332022.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-launches-101332022.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-24T10:13:32+00:00", "published_display": "24 Sep 2026 10:13", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["TMO.ARCHIVE", "TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "368a072b34e5285fd07455c41c5c4ddef5c8ed85e81f76867162d70682595f77", "target_scope": "Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return of 5.81%, building on a strong 90-day share price return of 31.55% as launches like the Gibco CHO-K1 Catalog Panel feed into a broader pipeline story.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.51, "provider_directional_mass": 0.1848, "relevance_score": 0.795492, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008939, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 18.4, "age_days": 4.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Balance Sheet", "Biologics", "Earnings", "Earnings Growth", "Healthcare", "Pharma"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific Launches Gibco\u2122 CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development", "summary": "New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: Gibco\u2122 CHO-K1 Catalog Panel Media and Feed Category: Basal and feed media for CHO-K1 cell culture Key benefit: Multiple ready-to-use media and feed options help developers rapidly identify high-performing combinations for CHO-K1 processes Additional benefits: Chemically defined, animal origin-fre", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-launches-gibco-123000578.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-launches-gibco-123000578.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-23T12:30:00+00:00", "published_display": "23 Sep 2026 12:30", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "feb47281679545ff4805c1ede2d12ef2eff0b34c9515b08e069032b667c3fe65", "target_scope": "Thermo Fisher Scientific Launches Gibco\u2122 CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.143, "relevance_score": 0.72, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005558, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 13.5, "age_days": 5.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biologics", "Cell Culture", "Process Optimization"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue", "summary": "Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Content Screening (HCS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global market for High Content Screening (HCS) was valued at US$1.3 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030. This comprehensive report provides an in-depth a", "url": "https://finance.yahoo.com/healthcare/articles/capitalize-high-content-screening-disruption-081900540.html", "source_link": "https://finance.yahoo.com/healthcare/articles/capitalize-high-content-screening-disruption-081900540.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-22T08:19:00+00:00", "published_display": "22 Sep 2026 08:19", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["DHR.US", "RVTY.US", "TMO.ARCHIVE", "TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "3cb9822dc57df65ac4f865ba301ab9f517d632b76b9238f90040d0c4951e55e8", "target_scope": "Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.145, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.025343, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 38.1, "age_days": 7.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biomedical Research", "Cancer Research", "Drug Discovery", "Imaging Technologies", "Market Research Reports", "Personalized Medicine"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI", "summary": "Company Logo AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Throughput Screening (HTS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global market for High Throughput Screening (HTS) was estimated at US$42.9 Billion in 2024 and is projected to reach US$45.3 Billion by 2030, growing at a CAGR of 0.9% from 2024 to 2030. This comprehensive report provides an in-depth an", "url": "https://finance.yahoo.com/healthcare/articles/capitalize-high-throughput-screening-shift-081700866.html", "source_link": "https://finance.yahoo.com/healthcare/articles/capitalize-high-throughput-screening-shift-081700866.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-22T08:17:00+00:00", "published_display": "22 Sep 2026 08:17", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TN8.DU", "provider_symbols": ["TMO.ARCHIVE", "TMO.US", "TN8.DU"], "target_provider_symbol": "TN8.DU", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "8c9210d6e896db12ac70100db094d6833023a3f342fafb4e1b2c924f81210e78", "target_scope": "Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.1291, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003874, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 9.0, "age_days": 7.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Automation", "Biotech", "Drug Discovery", "Market Research Reports", "Pharma", "Robotics"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "\u00bfEst\u00e1 la revisi\u00f3n al alza de las previsiones modificando el argumento de inversi\u00f3n de las acciones de Thermo Fisher (TMO)?", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-19T12:39:28+00:00", "published_display": "19 Sep 2026 12:39", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["simplywall.st"], "source_kind": "publisher", "story_key": "1399f2e6248f0550f820a6f63650e81d57ae6cf68627d9c28d7e6056fae4f547", "target_scope": "\u00bfEst\u00e1 la revisi\u00f3n al alza de las previsiones modificando el argumento de inversi\u00f3n de las acciones de Thermo Fisher (TMO)?", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001982, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) is Positioned for Resurgence", "summary": "Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among AI-related investments, supported the rally. Technology, particularly semiconductors, led performance as demand for AI infrastructure surged. Despite macroeconomic uncertainties and interest rate infl", "url": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-tmo-positioned-143434079.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-tmo-positioned-143434079.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-18T14:34:34+00:00", "published_display": "18 Sep 2026 14:34", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["RYAN.US", "TMO.ARCHIVE", "TMO.US", "TYL.US"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "04be378507a884f0a3308491d33167905791b0bfa8dbd6941602ef87b4f79d6c", "target_scope": "Thermo Fisher Scientific (TMO) is Positioned for Resurgence", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.167, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001061, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.5, "age_days": 10.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Earnings Growth", "Investment Management", "Life Sciences", "Semiconductors", "Technology"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Three Analysts, Three Verdicts on Thermo Fisher: Here\u2019s Who the Numbers Favor", "summary": "Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor \u00a9TIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) has become the rare large-cap where three analysts studying the same company cannot agree on direction. On September 3, CLSA started coverage at Outperform with a $748 target. On September 9, UBS upgraded the stock to Buy from Neutral and lifted its target to $730 from $540, a move that came as the firm assum", "url": "https://finance.yahoo.com/markets/stocks/articles/three-analysts-three-verdicts-thermo-141149279.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/three-analysts-three-verdicts-thermo-141149279.html", "source_link_is_lookup": false, "source_name": "TIKR", "published_at": "2026-09-17T14:11:49+00:00", "published_display": "17 Sep 2026 14:11", "provider": "archive", "providers": ["archive", "eodhd", "google_news"], "provider_symbol": "TMO.US", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["TIKR", "TIKR.com", "finance.yahoo.com", "tikr.com"], "source_kind": "publisher", "story_key": "363b70499167606f4df7964f16de4740666716096c88dacfb08944db96f9f882", "target_scope": "Three Analysts, Three Verdicts on Thermo Fisher: Here\u2019s Who the Numbers Favor Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor \u00a9TIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) has become the rare large-cap where three analysts studying the same company cannot agree on direction.", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.9, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.004228, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.7, "age_days": 11.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Biotech", "Earnings", "Net Income", "Pharma", "Price Target", "Upgrade Downgrade"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform?", "summary": "Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. Precure plans to integrate proteomic, genomic, and longitudinal clinical records into a single biomedical dataset to identify early disease signals. The collaboration positions Thermo Fisher Scientific's technology at the center of large scale healthcare data generation for research and clinical decision support. The Precure, LLC launch is important, but investors should weigh it alongside other Thermo Fisher Scientific risk signals. Our analysis turns ", "url": "https://finance.yahoo.com/healthcare/articles/why-thermo-fisher-scientific-tmo-131158873.html", "source_link": "https://finance.yahoo.com/healthcare/articles/why-thermo-fisher-scientific-tmo-131158873.html", "source_link_is_lookup": false, "source_name": "Simply Wall St.", "published_at": "2026-09-17T13:11:58+00:00", "published_display": "17 Sep 2026 13:11", "provider": "yfinance", "providers": ["archive", "eodhd", "yfinance"], "provider_symbol": "TN8.F", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.MX", "cross_listing": false, "source_names": ["Simply Wall St.", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "baa951aa3a7f9c6d2b783878106a65bc9fa0614b0a63c640d08964a21e8d943d", "target_scope": "Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform? Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. The collaboration positions Thermo Fisher Scientific's technology at the center of large scale healthcare data generation for research and clinical decision support. investors should weigh it alongside other Thermo Fisher Scientific risk signals.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.795492, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000812, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.7, "age_days": 11.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Collaboration", "Healthcare", "Research"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Sees Stronger Demand, Calls 2026 an \u2018Outstanding Year\u2019", "summary": "Key Points Interested in Thermo Fisher Scientific Inc.? Here are five stocks we like better. Thermo Fisher raised its outlook after returning to 5% organic growth in the second quarter, with adjusted EPS up 13%. CEO Marc Casper expects about 4% organic growth in 2026 and called it an \"outstanding year,\" citing orders running ahead of revenue. Pharma and biotech demand is strengthening as customers invest in drug-development pipelines, AI, and emerging therapies. Recovering biotech funding, mergers and acquisitions, and IPO activity are also supporting spending across clinical research, laborat", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-sees-stronger-demand-100208200.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-sees-stronger-demand-100208200.html", "source_link_is_lookup": false, "source_name": "MarketBeat", "published_at": "2026-09-17T10:02:08+00:00", "published_display": "17 Sep 2026 10:02", "provider": "archive", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["MarketBeat", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "192be29c081714c2318cdd343d7d4068ca87bff20242bbef5fe566e3a805c42b", "target_scope": "Thermo Fisher Sees Stronger Demand, Calls 2026 an \u2018Outstanding Year\u2019 Key Points Interested in Thermo Fisher Scientific Inc.? Thermo Fisher raised its outlook after returning to 5% organic growth in the second quarter, with adjusted EPS up 13%.", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.6000000000000001, "provider_directional_mass": null, "relevance_score": 0.9, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Guidance raised"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.024869, "evidence_share": 35.7, "evidence_share_display": "35.7", "freshness_pct": 19.2, "age_days": 11.9, "influence_label": "Medium", "evidence_strength": 38, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Clinical Research", "Earnings", "Earnings Per Share", "Growth Rate"], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "Thermo Fisher CEO Says AI Will Drive More Pharma Spending \u2014 Sees 7% Organic Growth By 2028", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-ceo-says-ai-171619596.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-ceo-says-ai-171619596.html", "source_link_is_lookup": false, "source_name": "Stocktwits", "published_at": "2026-09-15T17:16:19+00:00", "published_display": "15 Sep 2026 17:16", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["Stocktwits"], "source_kind": "publisher", "story_key": "31a9e05d1a90146a4dd2bfa3de5e0a7735f0606c6575e8525180103f6441bbbc", "target_scope": "Thermo Fisher CEO Says AI Will Drive More Pharma Spending", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000555, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.9, "age_days": 13.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear", "summary": "Pioneering initiative will generate data at the frontier of healthcare to help transform early biological signals into new opportunities for prevention, diagnosis and treatment ROCHESTER, Minn. and WALTHAM, Mass., Sept. 15, 2026 /PRNewswire/ -- Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.Mayo Clinic Precure, LLC will create one of the world's leading biomedical d", "url": "https://finance.yahoo.com/healthcare/articles/mayo-clinic-thermo-fisher-scientific-120000321.html", "source_link": "https://finance.yahoo.com/healthcare/articles/mayo-clinic-thermo-fisher-scientific-120000321.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-15T12:00:00+00:00", "published_display": "15 Sep 2026 12:00", "provider": "archive", "providers": ["archive", "eodhd"], "provider_symbol": "TN8.F", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["PR Newswire", "finance.yahoo.com"], "source_kind": "press_release", "story_key": "1cfad9b4f6fa9150e02c7290e6c1e7edb5e3778e9bcfddf5cd5d1862484b82e2", "target_scope": "Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear 15, 2026 /PRNewswire/ -- Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.Mayo Clinic Precure, LLC will create one of the world's leading biomedical d", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000447, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.8, "age_days": 13.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Data Analytics", "Diagnostics", "Healthcare Innovation", "Therapeutics"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "\u00bfEst\u00e1 Thermo Fisher Scientific (TMO) Cara Tras Lanzar Multiskan Ease?", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-15T07:00:00+00:00", "published_display": "15 Sep 2026 07:00", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["TMO.ARCHIVE"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["simplywall.st"], "source_kind": "publisher", "story_key": "b8adda2334f1114737e2f028e1dcb25bcacdca44cb0fe5a7b2a176a60ecd2f6e", "target_scope": "\u00bfEst\u00e1 Thermo Fisher Scientific (TMO) Cara Tras Lanzar Multiskan Ease?", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000478, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.8, "age_days": 14.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "Analysts See Thermo Fisher at $748 Here\u2019s Where the Stock Could Go", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOakd2T3NOd3BXVFhnd25ENHhkcDRJYXdEbTJUWi1GR2FEU0ZwRmFXZ0pzQUdmblFrQkU5TnBMek9RSmI2bGUyQTJKNmZHM0tVRjRGbVYxdER4Mkc2eDlNOFZZMm5QMWlBbk1NRXBKLTcyTE8xREYxZ2VsSkZoMUZIeXNvMEV6NlNHbU96N1h0X3plOXE1RXhXQkd5TDc4eEFKbUZzTm1EMUFhUQ?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOakd2T3NOd3BXVFhnd25ENHhkcDRJYXdEbTJUWi1GR2FEU0ZwRmFXZ0pzQUdmblFrQkU5TnBMek9RSmI2bGUyQTJKNmZHM0tVRjRGbVYxdER4Mkc2eDlNOFZZMm5QMWlBbk1NRXBKLTcyTE8xREYxZ2VsSkZoMUZIeXNvMEV6NlNHbU96N1h0X3plOXE1RXhXQkd5TDc4eEFKbUZzTm1EMUFhUQ?oc=5", "source_link_is_lookup": false, "source_name": "tikr.com", "published_at": "2026-09-11T15:45:00+00:00", "published_display": "11 Sep 2026 15:45", "provider": "google_news", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["TMO.ARCHIVE"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["TIKR.com", "tikr.com"], "source_kind": "publisher", "story_key": "c674681c847d2a6c772c80cba01c8f351cfb75549d2bb41ddfe16144b045984d", "target_scope": "Analysts See Thermo Fisher at $748 Here\u2019s Where the Stock Could Go", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000136, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.2, "age_days": 17.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says", "summary": "Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-danaher-could-log-175546656.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-danaher-could-log-175546656.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-09-09T17:55:46+00:00", "published_display": "09 Sep 2026 17:55", "provider": "archive", "providers": ["archive", "eodhd"], "provider_symbol": "TMOS34.SA", "provider_symbols": ["DHR", "DHR.US", "TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US", "TN8.DU"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["MT Newswires", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "1d42ca5cdcf4925a2276e74b55c4521623abb0bc6a77088895964a08c3ffd4eb", "target_scope": "Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re PREMIUM Upgrade to read this MT Newswires article and get so much more.", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.54, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 58, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006976, "evidence_share": 10.0, "evidence_share_display": "10", "freshness_pct": 6.6, "age_days": 19.6, "influence_label": "Low", "evidence_strength": 32, "duplicate_count": 1, "topics": [], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls", "summary": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: UBS upgraded Thermo Fisher(TMO) to Buy from Neutral with a price target of $730, up from $540, after a transfer in analyst coverage. Thermo Fisher is positioned for a durable return to 5%-6%-plus organic growth in 2027, supported by improving pharma/biotech funding, bioprocessing demand, reshoring, AI-driven R&D investment, share", "url": "https://finance.yahoo.com/markets/stocks/articles/uber-initiated-thermo-fisher-upgraded-135116768.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/uber-initiated-thermo-fisher-upgraded-135116768.html", "source_link_is_lookup": false, "source_name": "The Fly", "published_at": "2026-09-09T13:51:16+00:00", "published_display": "09 Sep 2026 13:51", "provider": "archive", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["AFRM", "AFRM.US", "AMRZ", "AMRZ.US", "CHYM", "CHYM.US", "CI", "DASH", "DASH.US", "DYN", "DYN.US", "EXP", "EXP.US", "FIGR", "FIGR.US", "FSLR", "FSLR.US", "KLAR", "KLAR.US", "LINE", "LINE.US", "LYFT", "LYFT.US", "META", "META.US", "MLM", "MLM.US", "NVS", "NVS.US", "OKLO", "OKLO.US", "PAX", "PAX.US", "PWR", "PWR.US", "SMMT", "SMMT.US", "TMO", "TMO.ARCHIVE", "TMO.MX", "TMO.US", "UBER", "UBER.US", "VMC", "VMC.US", "WLK", "WLK.US"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["The Fly", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "070a151dc8afdf5711a1d92c88538825dd46f13411c4e0df62402d2af767b459", "target_scope": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Top 5 Upgrades: UBS upgraded Thermo Fisher(TMO) to Buy from Neutral with a price target of $730, up from $540, after a transfer in analyst coverage. Thermo Fisher is positioned for a durable return to 5%-6%-plus organic growth in 2027, supported by improving pharma/biotech funding, bioprocessing demand, reshoring, AI-driven R&D investment, share", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "target_heuristic", "model_confidence": 0.595, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 56, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000934, "evidence_share": 1.3, "evidence_share_display": "1.3", "freshness_pct": 1.0, "age_days": 19.7, "influence_label": "Low", "evidence_strength": 26, "duplicate_count": 1, "topics": ["Biotech", "Construction Materials", "Pharma", "Price Target", "Revenue Growth"], "evidence_basis": "archived_article", "score_included": true, "direction_included": true}, {"title": "UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/ubs-upgrades-thermo-fisher-scientific-132027711.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/ubs-upgrades-thermo-fisher-scientific-132027711.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-09-09T13:20:27+00:00", "published_display": "09 Sep 2026 13:20", "provider": "archive", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["TMO", "TMO.ARCHIVE", "TMO.MX"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["MT Newswires"], "source_kind": "publisher", "story_key": "44021c72cf5184ad6fdb94f3affba8a008150ffa2c1dcfde3295cbaa4b4924f8", "target_scope": "UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540", "durable_archive": true, "archive_provider": "yfinance", "sentiment_origin": "target_heuristic", "model_confidence": 0.6299999999999999, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 69, "tone_signals": ["Analyst upgrade"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001711, "evidence_share": 2.5, "evidence_share_display": "2.5", "freshness_pct": 1.0, "age_days": 19.7, "influence_label": "Medium", "evidence_strength": 43, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": true}, {"title": "Should You Continue to Hold TMO Stock in Your Portfolio?", "summary": "Thermo Fisher Scientific Inc.'s TMO growth continues to benefit from a broader pickup in customer activity. The company is using acquisitions to move deeper into some of the more attractive corners of the life sciences market while strengthening ties with customers. At the same time, the company is improving its debt position while continuing to return cash to shareholders. Yet, a challenging macroeconomic environment and intense competition could weigh on Thermo Fisher's results. In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 6.7% against the 8.2% decline of the in", "url": "https://finance.yahoo.com/markets/stocks/articles/continue-hold-tmo-stock-portfolio-143500428.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/continue-hold-tmo-stock-portfolio-143500428.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-04T14:35:00+00:00", "published_display": "04 Sep 2026 14:35", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["GMED.US", "GSPC.INDX", "TFX.US", "TMO.ARCHIVE", "TMO.US", "VCYT.US"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "45380f103806a055bb48ded13e5691498b5d411ca6dbd941e276d6c98959d231", "target_scope": "Should You Continue to Hold TMO Stock in Your Portfolio? Thermo Fisher Scientific Inc.'s TMO growth continues to benefit from a broader pickup in customer activity. but The company is using acquisitions to move deeper into some of the more attractive corners of the life sciences market Yet, a challenging macroeconomic environment and intense competition could weigh on Thermo Fisher's results.", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.187, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005187, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 8.7, "age_days": 24.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Acquisitions", "Biotech", "Debt", "Earnings", "Earnings Growth", "Earnings Per Share"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Las acciones de Thermo Fisher Scientific (TMO) parecen estar cerca de su valor razonable tras una subida del 24 %", "summary": "", "url": "https://news.google.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?oc=5", "source_link": "https://news.google.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?oc=5", "source_link_is_lookup": false, "source_name": "simplywall.st", "published_at": "2026-09-02T09:47:20+00:00", "published_display": "02 Sep 2026 09:47", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["TMO.ARCHIVE"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["simplywall.st"], "source_kind": "publisher", "story_key": "63bd84446f46e3482c86a337aebaf23def608441b8e3504f765490bf5a0571c2", "target_scope": "Las acciones de Thermo Fisher Scientific (TMO) parecen estar cerca de su valor razonable tras una subida del 24 %", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 6e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 26.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "TMO Stock Could Gain Following the Launch of EMPAD G2 Detector", "summary": "Thermo Fisher Scientific Inc. TMO recently unveiled the Thermo Scientific EMPAD G2 detector to help researchers analyze materials in unprecedented detail. This development is expected to bolster the company's Analytical Instruments segment. TMO Stock Outlook Following the News After the announcement, TMO shares dipped slightly by 0.8% last Thursday. On a positive note, Thermo Fisher has steadily ramped up R&D investments in recent years, fueling new product launches and enhancing its portfolio. We expect the latest development to improve investor sentiment toward TMO stock and support its upwa", "url": "https://finance.yahoo.com/healthcare/articles/tmo-stock-could-gain-following-182900842.html", "source_link": "https://finance.yahoo.com/healthcare/articles/tmo-stock-could-gain-following-182900842.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-01T18:29:00+00:00", "published_display": "01 Sep 2026 18:29", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TMO.US", "provider_symbols": ["GMED.US", "ILMN.US", "ILU.DU", "TMO.ARCHIVE", "TMO.US", "VCYT.US"], "target_provider_symbol": "TMO.US", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "0b4ba190aeebce92e095123774b8c5227b6579c5625b6671d9802bb654f95004", "target_scope": "TMO Stock Could Gain Following the Launch of EMPAD G2 Detector Thermo Fisher Scientific Inc. TMO recently unveiled the Thermo Scientific EMPAD G2 detector to help researchers analyze materials in unprecedented detail. TMO Stock Outlook Following the News After the announcement, TMO shares dipped slightly by 0.8% last Thursday. On a positive note, Thermo Fisher has steadily ramped up R&D investments in recent years, fueling new product launches and enhancing its portfolio. We expect the latest development to improve investor sentiment toward TMO stock and support its upwa", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.54, "provider_directional_mass": 0.151, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 54, "tone_signals": ["Positive financial language"], "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006853, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.5, "age_days": 27.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Advanced Materials", "Earnings", "Earnings Growth", "Energy", "Medical", "Semiconductors"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026", "summary": "WALTHAM, Mass., September 01, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET). You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-present-morgan-120000343.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-present-morgan-120000343.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-01T12:00:00+00:00", "published_display": "01 Sep 2026 12:00", "provider": "eodhd", "providers": ["archive", "eodhd"], "provider_symbol": "TN8.DU", "provider_symbols": ["TMO.ARCHIVE", "TMO.US", "TN8.DU"], "target_provider_symbol": "TN8.DU", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "f9f52cd7d1697fd75cff30eff94526c2b68406e916d6038065cce017000cc637", "target_scope": "Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 WALTHAM, Mass., September 01, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion.", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.087, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001409, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.1, "age_days": 27.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Healthcare"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis", "summary": "Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced research and data intensive science through 56 AI infrastructure stocks.NYSE:TMO Earnings & Revenue Growth a", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-unveils-230701731.html", "source_link": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-scientific-tmo-unveils-230701731.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-31T23:07:01+00:00", "published_display": "31 Aug 2026 23:07", "provider": "eodhd", "providers": ["eodhd"], "provider_symbol": "TMOS34.SA", "provider_symbols": ["TMO.ARCHIVE", "TMO.MX", "TMO.US", "TMOS34.SA"], "target_provider_symbol": "TMOS34.SA", "cross_listing": false, "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "df3d8a0cc62baae0b25e3adb90a1c3ee8b6faf997fc89ec3a1fb6547c3887af5", "target_scope": "Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. but The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. Consider looking at other stocks developing tools and infrastructure that support advanced research and data intensive science through 56 AI infrastructure stocks.NYSE:TMO Earnings & Revenue Growth a", "durable_archive": true, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.5920000000000001, "provider_directional_mass": 0.08, "relevance_score": 0.78, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 55, "tone_signals": ["Operating growth"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001928, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 2.0, "age_days": 28.3, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Life Sciences", "Mass Spectrometry", "Microscopy"], "evidence_basis": "archived_article", "score_included": true, "direction_included": false}, {"title": "Thermo Fisher Is Up 23% in a Year. Is It Too Late to Buy at $622?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORXlGYnVfcmI3eVhjd2h1d2dEQURURU1RclVJVnE2RlVuNUhuUWxnZ0UxSFlTNFJodGZjVHNiSHpYMVR4LWYxMElidDJBUjlaNjlNMjE5R1hHV2J3UlFXYUdwOFQwYjBIaU9taHJhY3FZN0pTcXExaTNRX2ZRVVVjNWloLVBiS21hX1NqWnIwRDRkU20w?oc=5", "source_link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORXlGYnVfcmI3eVhjd2h1d2dEQURURU1RclVJVnE2RlVuNUhuUWxnZ0UxSFlTNFJodGZjVHNiSHpYMVR4LWYxMElidDJBUjlaNjlNMjE5R1hHV2J3UlFXYUdwOFQwYjBIaU9taHJhY3FZN0pTcXExaTNRX2ZRVVVjNWloLVBiS21hX1NqWnIwRDRkU20w?oc=5", "source_link_is_lookup": false, "source_name": "TIKR.com", "published_at": "2026-08-30T18:50:14+00:00", "published_display": "30 Aug 2026 18:50", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["TMO.ARCHIVE"], "target_provider_symbol": "TMO.ARCHIVE", "cross_listing": false, "source_names": ["TIKR.com", "tikr.com"], "source_kind": "publisher", "story_key": "a36a72257ebd1254fca7f6d5c31716bc01127f1d5cf638db724f8bbecb6ffe26", "target_scope": "Thermo Fisher Is Up 23% in a Year.", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 2e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 29.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}], "industry": [], "sector": []}, "total_fetched": 25, "total_unique": 25, "total_relevant": 25, "pipeline_health": {"status": "partial", "providers_attempted": 3, "providers_with_results": 2, "raw_articles": 133, "unique_stories": 112, "duplicates_removed": 21, "relevant_stories": 25, "matched_archive_stories": 26, "current_evidence": 5, "direct_evidence": 25, "archive_articles": 11, "durable_story_count": 25, "durable_evidence_used": true, "durable_collected_at": "2026-09-28T14:54:16.303201+00:00"}, "sentiment_summary": {"positive": 5, "negative": 0, "neutral": 20, "score": 51, "raw_score": 58, "total": 25, "evidence_count": 5, "effective_articles": 2.54, "information_mass": 0.07, "direct_story_count": 25, "directional_story_count": 5, "direct_source_count": 4, "industry_story_count": 0, "sector_story_count": 0, "story_count": 25, "source_count": 4, "source_concentration": 0.3981, "direct_share": 79, "dispersion": 2, "confidence": 20, "evidence_status": "provisional", "score_version": "evidence-v11", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-09-28T12:00:00+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 8.18, "count": 14}, {"event": "earnings", "label": "Earnings", "weight": 3.4, "count": 6}, {"event": "analyst", "label": "Analyst action", "weight": 1.8, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 0, "pipeline": {"status": "partial", "providers_attempted": 3, "providers_with_results": 2, "raw_articles": 133, "unique_stories": 112, "duplicates_removed": 21, "relevant_stories": 25, "matched_archive_stories": 26, "current_evidence": 5, "direct_evidence": 25, "archive_articles": 11, "durable_story_count": 25, "durable_evidence_used": true, "durable_collected_at": "2026-09-28T14:54:16.303201+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 11900.0, "latest_week": "2026-09-25", "one_week_move": 5.1, "four_week_move": 11.9, "twelve_week_move": 29.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.548215, "market_dynamics_buy_signal": false, "relative_strength": 25.163109, "fair_value_gap": 22.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 45.6122, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.1% over one week, +11.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 20, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 12}, {"label": "simplywall.st", "count": 3}, {"label": "MT Newswires", "count": 2}, {"label": "TIKR", "count": 1}, {"label": "Simply Wall St.", "count": 1}, {"label": "MarketBeat", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "PR Newswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 14}, {"label": "Earnings", "count": 6}, {"label": "Analyst action", "count": 3}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "20/100", "tone": "neutral", "text": "2.54 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "79% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "2/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.1% over one week, +11.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026"}], "updated_at": "2026-09-28T14:54:16.303201+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "25 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 51, "display": "51", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 20, "display": "20", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 79, "display": "79%", "tone": "positive", "note": "25 company stories"}, {"label": "Story agreement", "value": 98, "display": "98", "tone": "positive", "note": "2/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 1, "note": "0.073 after freshness weighting"}, {"label": "Source breadth", "value": 80, "note": "4 independent publishers"}, {"label": "Company relevance", "value": 79, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 52, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 98, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 60, "note": "less reliance on one publisher"}], "influence": {"events": [{"label": "Market update", "positive": 0.037749, "negative": 0.0, "count": 1, "positive_share": 51.5, "positive_width": 50.0, "negative_share": 0.0, "negative_width": 0.0}, {"label": "Earnings", "positive": 0.032753, "negative": 0.0, "count": 2, "positive_share": 44.7, "positive_width": 43.383, "negative_share": 0.0, "negative_width": 0.0}, {"label": "Analyst action", "positive": 0.002772, "negative": 0.0, "count": 2, "positive_share": 3.8, "positive_width": 3.672, "negative_share": 0.0, "negative_width": 0.0}], "sources": [{"label": "finance.yahoo.com", "weight": 0.037749, "count": 1, "share": 51.5}, {"label": "MarketBeat", "weight": 0.025578, "count": 1, "share": 34.9}, {"label": "MT Newswires", "weight": 0.008968, "count": 2, "share": 12.2}, {"label": "The Fly", "weight": 0.000979, "count": 1, "share": 1.3}], "directional_count": 5, "retained_count": 25, "source_count": 4, "top_share": 51.5, "axis_max": 51.5}, "freshness": 52, "source_independence": 60, "timeline": [{"date": "2026-08-31", "label": "31 Aug", "count": 1, "score": 55, "tone": "neutral", "x": 42.0, "y": 125.9, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-01", "label": "01 Sep", "count": 2, "score": 53, "tone": "neutral", "x": 73.6, "y": 129.5, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-09-02", "label": "02 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-03", "label": "03 Sep", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-04", "label": "04 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-05", "label": "05 Sep", "count": 0, "score": null, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-06", "label": "06 Sep", "count": 0, "score": null, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-07", "label": "07 Sep", "count": 0, "score": null, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-08", "label": "08 Sep", "count": 0, "score": null, "tone": "neutral", "x": 294.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-09", "label": "09 Sep", "count": 3, "score": 60, "tone": "positive", "x": 326.3, "y": 116.8, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-09-10", "label": "10 Sep", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-11", "label": "11 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-12", "label": "12 Sep", "count": 0, "score": null, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-13", "label": "13 Sep", "count": 0, "score": null, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-14", "label": "14 Sep", "count": 0, "score": null, "tone": "neutral", "x": 484.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-15", "label": "15 Sep", "count": 3, "score": 50, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-09-16", "label": "16 Sep", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-17", "label": "17 Sep", "count": 3, "score": 57, "tone": "neutral", "x": 579.0, "y": 122.3, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-09-18", "label": "18 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-19", "label": "19 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-20", "label": "20 Sep", "count": 0, "score": null, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-21", "label": "21 Sep", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-22", "label": "22 Sep", "count": 2, "score": 50, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-09-23", "label": "23 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-24", "label": "24 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-25", "label": "25 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-26", "label": "26 Sep", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-27", "label": "27 Sep", "count": 1, "score": 57, "tone": "neutral", "x": 894.8, "y": 122.3, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-28", "label": "28 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-29", "label": "29 Sep", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "42.0,125.9 73.6,129.5 105.2,135.0 168.3,135.0 326.3,116.8 389.4,135.0 515.8,135.0 579.0,122.3 610.6,135.0 642.1,135.0 736.9,135.0 768.5,135.0 800.1,135.0 831.7,135.0 894.8,122.3 926.4,135.0", "timeline_path": "M42.0,125.9 L73.6,129.5 L105.2,135.0 M168.3,135.0 M326.3,116.8 M389.4,135.0 M515.8,135.0 M579.0,122.3 L610.6,135.0 L642.1,135.0 M736.9,135.0 L768.5,135.0 L800.1,135.0 L831.7,135.0 M894.8,122.3 L926.4,135.0", "timeline_has_signal": true, "timeline_start": "31 Aug", "timeline_mid": "15 Sep", "timeline_end": "29 Sep", "momentum": {"label": "Stable but thin", "tone": "neutral", "recent_score": 53, "prior_score": 50, "delta": 3, "recent_count": 2, "prior_count": 3, "volume_delta": -1, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "New stories need a baseline", "tone": "neutral", "latest_score": 50, "baseline_score": 53, "delta": null, "latest_count": 1, "baseline_count": 6, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 1, "share": 4}, {"label": "1 to 3 days", "count": 1, "share": 4}, {"label": "4 to 7 days", "count": 5, "share": 20}, {"label": "8 to 14 days", "count": 8, "share": 32}, {"label": "15 to 21 days", "count": 4, "share": 16}, {"label": "22 to 30 days", "count": 6, "share": 24}], "source_profile": [{"label": "finance.yahoo.com", "count": 12, "share": 48, "score": 52, "tone": "neutral"}, {"label": "simplywall.st", "count": 3, "share": 12, "score": 50, "tone": "neutral"}, {"label": "MT Newswires", "count": 2, "share": 8, "score": 60, "tone": "positive"}, {"label": "MarketBeat", "count": 1, "share": 4, "score": 58, "tone": "positive"}, {"label": "The Fly", "count": 1, "share": 4, "score": 56, "tone": "neutral"}, {"label": "TIKR", "count": 1, "share": 4, "score": 50, "tone": "neutral"}, {"label": "Simply Wall St.", "count": 1, "share": 4, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Market update", "count": 14, "share": 56, "score": 53, "tone": "neutral"}, {"label": "Earnings", "count": 6, "share": 24, "score": 52, "tone": "neutral"}, {"label": "Analyst action", "count": 3, "share": 12, "score": 56, "tone": "neutral"}, {"label": "Guidance", "count": 1, "share": 4, "score": 54, "tone": "neutral"}, {"label": "Deals and strategy", "count": 1, "share": 4, "score": 50, "tone": "neutral"}], "topics": [{"label": "Earnings", "count": 10, "share": 40}, {"label": "Biotech", "count": 10, "share": 40}, {"label": "Pharma", "count": 6, "share": 24}, {"label": "Earnings Growth", "count": 4, "share": 16}, {"label": "Life Sciences", "count": 3, "share": 12}, {"label": "Healthcare", "count": 3, "share": 12}, {"label": "Acquisitions", "count": 3, "share": 12}, {"label": "Semiconductors", "count": 2, "share": 8}, {"label": "Price Target", "count": 2, "share": 8}, {"label": "Market Research Reports", "count": 2, "share": 8}], "supporting": [{"label": "Direct evidence", "text": "25 current stories are mapped specifically to TMO."}, {"label": "Source breadth", "text": "The score uses 4 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.073."}, {"label": "Confidence", "text": "Confidence is 20/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026", "summary": "WALTHAM, Mass., September 28, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the \"Investors\" section of our website, www.thermofisher.com under the subheading \"News, Events and Presentations\". You can access t", "url": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/thermo-fisher-scientific-hold-earnings-120000258.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-09-28T12:00:00+00:00", "published_display": "28 Sep 2026 12:00", "source_kind": "aggregator", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.058388, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 92.0, "age_days": 0.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Results", "Quarterly Earnings"], "evidence_basis": "", "score_included": true, "direction_included": false}, "article_count": 25, "updated_at": "2026-09-28T14:54:16.303201+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 163.9, "label": "03 Apr 2026", "close": 8765.19043, "index": 100.0}, {"x": 78.4, "y": 168.0, "label": "10 Apr 2026", "close": 8648.0, "index": 98.7}, {"x": 114.9, "y": 151.3, "label": "17 Apr 2026", "close": 9130.496094, "index": 104.2}, {"x": 151.3, "y": 191.6, "label": "24 Apr 2026", "close": 7962.560547, "index": 90.8}, {"x": 187.7, "y": 183.5, "label": "01 May 2026", "close": 8199.547852, "index": 93.5}, {"x": 224.2, "y": 192.7, "label": "08 May 2026", "close": 7931.972168, "index": 90.5}, {"x": 260.6, "y": 204.2, "label": "15 May 2026", "close": 7598.590332, "index": 86.7}, {"x": 297.0, "y": 200.6, "label": "22 May 2026", "close": 7703.574707, "index": 87.9}, {"x": 333.5, "y": 169.8, "label": "29 May 2026", "close": 8596.625, "index": 98.1}, {"x": 369.9, "y": 181.2, "label": "05 Jun 2026", "close": 8266.021783, "index": 94.3}, {"x": 406.3, "y": 173.0, "label": "12 Jun 2026", "close": 8503.632897, "index": 97.0}, {"x": 442.8, "y": 188.1, "label": "19 Jun 2026", "close": 8064.02002, "index": 92.0}, {"x": 479.2, "y": 159.0, "label": "26 Jun 2026", "close": 8910.0, "index": 101.7}, {"x": 515.6, "y": 149.2, "label": "03 Jul 2026", "close": 9192.650391, "index": 104.9}, {"x": 552.0, "y": 149.3, "label": "10 Jul 2026", "close": 9190.0, "index": 104.8}, {"x": 588.5, "y": 147.0, "label": "17 Jul 2026", "close": 9256.0, "index": 105.6}, {"x": 624.9, "y": 119.1, "label": "24 Jul 2026", "close": 10064.0, "index": 114.8}, {"x": 661.3, "y": 125.0, "label": "31 Jul 2026", "close": 9893.900391, "index": 112.9}, {"x": 697.8, "y": 125.5, "label": "07 Aug 2026", "close": 9880.0, "index": 112.7}, {"x": 734.2, "y": 114.9, "label": "14 Aug 2026", "close": 10186.955103, "index": 116.2}, {"x": 770.6, "y": 96.4, "label": "21 Aug 2026", "close": 10723.306843, "index": 122.3}, {"x": 807.1, "y": 99.4, "label": "28 Aug 2026", "close": 10635.53803, "index": 121.3}, {"x": 843.5, "y": 109.7, "label": "04 Sep 2026", "close": 10338.599107, "index": 118.0}, {"x": 879.9, "y": 112.8, "label": "11 Sep 2026", "close": 10248.69228, "index": 116.9}, {"x": 916.4, "y": 75.8, "label": "18 Sep 2026", "close": 11320.0, "index": 129.1}, {"x": 952.8, "y": 55.8, "label": "25 Sep 2026", "close": 11900.0, "index": 135.8}], "sentiment_points": [{"at": "2026-06-19T23:59:59.999Z", "date": "2026-06-19", "tone": "neutral", "close": 8064.02002, "label": "19 Jun 2026", "score": 50, "stories": 1, "raw_score": 57, "confidence": 29, "price_change": -5.2, "x": 448.0, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "tone": "neutral", "close": 8910.0, "label": "26 Jun 2026", "score": 50, "stories": 7, "raw_score": 57, "confidence": 19, "price_change": 10.5, "x": 484.4, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "tone": "neutral", "close": 9192.650391, "label": "03 Jul 2026", "score": 50, "stories": 13, "raw_score": 58, "confidence": 17, "price_change": 3.2, "x": 520.8, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "tone": "neutral", "close": 9190.0, "label": "10 Jul 2026", "score": 50, "stories": 16, "raw_score": 57, "confidence": 22, "price_change": 0.0, "x": 557.2, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "tone": "neutral", "close": 9256.0, "label": "17 Jul 2026", "score": 50, "stories": 21, "raw_score": 64, "confidence": 18, "price_change": 0.7, "x": 593.7, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "tone": "positive", "close": 10064.0, "label": "24 Jul 2026", "score": 65, "stories": 38, "raw_score": 72, "confidence": 57, "price_change": 8.7, "x": 630.1, "y": 102.4, "show_label": false, "label_y": 92.4}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "tone": "positive", "close": 9893.900391, "label": "31 Jul 2026", "score": 61, "stories": 38, "raw_score": 70, "confidence": 40, "price_change": -1.7, "x": 666.5, "y": 109.8, "show_label": true, "label_y": 99.8}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "tone": "neutral", "close": 9880.0, "label": "07 Aug 2026", "score": 56, "stories": 40, "raw_score": 65, "confidence": 29, "price_change": -0.1, "x": 703.0, "y": 119.0, "show_label": false, "label_y": 109.0}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "tone": "positive", "close": 10186.955103, "label": "14 Aug 2026", "score": 59, "stories": 53, "raw_score": 69, "confidence": 36, "price_change": 3.1, "x": 739.4, "y": 113.4, "show_label": false, "label_y": 103.4}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "tone": "neutral", "close": 10723.306843, "label": "21 Aug 2026", "score": 55, "stories": 49, "raw_score": 69, "confidence": 24, "price_change": 5.3, "x": 775.8, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "tone": "neutral", "close": 10635.53803, "label": "28 Aug 2026", "score": 53, "stories": 35, "raw_score": 68, "confidence": 20, "price_change": -0.8, "x": 812.3, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "tone": "neutral", "close": 10338.599107, "label": "04 Sep 2026", "score": 51, "stories": 34, "raw_score": 68, "confidence": 17, "price_change": -2.8, "x": 848.7, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "tone": "neutral", "close": 10248.69228, "label": "11 Sep 2026", "score": 52, "stories": 20, "raw_score": 63, "confidence": 25, "price_change": -0.9, "x": 885.1, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "tone": "neutral", "close": 11320.0, "label": "18 Sep 2026", "score": 51, "stories": 24, "raw_score": 59, "confidence": 25, "price_change": 10.5, "x": 921.6, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "tone": "neutral", "close": 11900.0, "label": "25 Sep 2026", "score": 51, "stories": 23, "raw_score": 59, "confidence": 18, "price_change": 5.1, "x": 958.0, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}], "price_path": "42.0,163.9 78.4,168.0 114.9,151.3 151.3,191.6 187.7,183.5 224.2,192.7 260.6,204.2 297.0,200.6 333.5,169.8 369.9,181.2 406.3,173.0 442.8,188.1 479.2,159.0 515.6,149.2 552.0,149.3 588.5,147.0 624.9,119.1 661.3,125.0 697.8,125.5 734.2,114.9 770.6,96.4 807.1,99.4 843.5,109.7 879.9,112.8 916.4,75.8 952.8,55.8", "sentiment_path": "448.0,130.0 484.4,130.0 520.8,130.0 557.2,130.0 593.7,130.0 630.1,102.4 666.5,109.8 703.0,119.0 739.4,113.4 775.8,120.8 812.3,124.5 848.7,128.2 885.1,126.3 921.6,128.2 958.0,128.2", "score_version": "evidence-v11", "price_change": 35.8, "sentiment_change": 1, "recent_pairs": [{"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "tone": "neutral", "close": 11900.0, "label": "25 Sep 2026", "score": 51, "stories": 23, "raw_score": 59, "confidence": 18, "price_change": 5.1, "x": 958.0, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "tone": "neutral", "close": 11320.0, "label": "18 Sep 2026", "score": 51, "stories": 24, "raw_score": 59, "confidence": 25, "price_change": 10.5, "x": 921.6, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "tone": "neutral", "close": 10248.69228, "label": "11 Sep 2026", "score": 52, "stories": 20, "raw_score": 63, "confidence": 25, "price_change": -0.9, "x": 885.1, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "tone": "neutral", "close": 10338.599107, "label": "04 Sep 2026", "score": 51, "stories": 34, "raw_score": 68, "confidence": 17, "price_change": -2.8, "x": 848.7, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "tone": "neutral", "close": 10635.53803, "label": "28 Aug 2026", "score": 53, "stories": 35, "raw_score": 68, "confidence": 20, "price_change": -0.8, "x": 812.3, "y": 124.5, "show_label": false, "label_y": 114.5}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "tone": "neutral", "close": 10723.306843, "label": "21 Aug 2026", "score": 55, "stories": 49, "raw_score": 69, "confidence": 24, "price_change": 5.3, "x": 775.8, "y": 120.8, "show_label": true, "label_y": 110.8}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "tone": "positive", "close": 10186.955103, "label": "14 Aug 2026", "score": 59, "stories": 53, "raw_score": 69, "confidence": 36, "price_change": 3.1, "x": 739.4, "y": 113.4, "show_label": false, "label_y": 103.4}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "tone": "neutral", "close": 9880.0, "label": "07 Aug 2026", "score": 56, "stories": 40, "raw_score": 65, "confidence": 29, "price_change": -0.1, "x": 703.0, "y": 119.0, "show_label": false, "label_y": 109.0}], "reconstructed": true, "latest_close": 11900.0, "price_observations": 26, "sentiment_observations": 15, "sentiment_start_label": "19 Jun 2026", "sentiment_end_label": "25 Sep 2026", "sentiment_history_limited": false, "price_axis_high": 141.7, "price_axis_mid": 111.2, "price_axis_low": 80.8, "start_label": "03 Apr", "mid_label": "30 Jun", "end_label": "25 Sep", "live_score_version": "evidence-v11", "comparable_to_live": true}, "sentiment_history": [{"tone": "neutral", "delta": 0, "label": "24 Jun 23:59", "score": 50, "height": 4, "articles": 5, "confidence": 25, "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score_change": null, "reconstructed": true, "score_version": "evidence-v11", "article_change": null, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": null, "score_change_display": "Start"}, {"tone": "neutral", "delta": 0, "label": "25 Jun 23:59", "score": 50, "height": 4, "articles": 6, "confidence": 21, "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -4, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "26 Jun 23:59", "score": 50, "height": 4, "articles": 7, "confidence": 19, "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "27 Jun 23:59", "score": 50, "height": 4, "articles": 8, "confidence": 18, "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "29 Jun 23:59", "score": 51, "height": 4, "articles": 11, "confidence": 27, "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 9, "score_change_display": "+1"}, {"tone": "neutral", "delta": 0, "label": "01 Jul 23:59", "score": 50, "height": 4, "articles": 12, "confidence": 20, "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -7, "score_change_display": "-1"}, {"tone": "neutral", "delta": 0, "label": "03 Jul 23:59", "score": 50, "height": 4, "articles": 13, "confidence": 17, "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "04 Jul 23:59", "score": 50, "height": 4, "articles": 14, "confidence": 24, "short_label": "04 Jul", "collected_at": "2026-07-04T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 7, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "07 Jul 23:59", "score": 50, "height": 4, "articles": 15, "confidence": 18, "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "09 Jul 23:59", "score": 50, "height": 4, "articles": 16, "confidence": 25, "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 7, "score_change_display": "+0"}, {"tone": "neutral", "delta": 0, "label": "13 Jul 23:59", "score": 50, "height": 4, "articles": 17, "confidence": 17, "short_label": "13 Jul", "collected_at": "2026-07-13T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -8, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "14 Jul 23:59", "score": 51, "height": 4, "articles": 18, "confidence": 26, "short_label": "14 Jul", "collected_at": "2026-07-14T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 9, "score_change_display": "+1"}, {"tone": "neutral", "delta": 1, "label": "15 Jul 23:59", "score": 51, "height": 4, "articles": 19, "confidence": 23, "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "16 Jul 23:59", "score": 51, "height": 4, "articles": 21, "confidence": 20, "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "20 Jul 23:59", "score": 51, "height": 4, "articles": 23, "confidence": 28, "short_label": "20 Jul", "collected_at": "2026-07-20T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 8, "score_change_display": "+0"}, {"tone": "neutral", "delta": 2, "label": "22 Jul 23:59", "score": 52, "height": 4, "articles": 25, "confidence": 31, "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 3, "score_change_display": "+1"}, {"tone": "positive", "delta": 14, "label": "23 Jul 23:59", "score": 64, "height": 28, "articles": 34, "confidence": 51, "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score_change": 12, "reconstructed": true, "score_version": "evidence-v11", "article_change": 9, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 20, "score_change_display": "+12"}, {"tone": "positive", "delta": 15, "label": "24 Jul 23:59", "score": 65, "height": 30, "articles": 38, "confidence": 57, "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 4, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 6, "score_change_display": "+1"}, {"tone": "positive", "delta": 13, "label": "27 Jul 23:59", "score": 63, "height": 26, "articles": 37, "confidence": 46, "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -11, "score_change_display": "-2"}, {"tone": "positive", "delta": 12, "label": "29 Jul 23:59", "score": 62, "height": 24, "articles": 35, "confidence": 41, "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -2, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -5, "score_change_display": "-1"}, {"tone": "positive", "delta": 11, "label": "30 Jul 23:59", "score": 61, "height": 22, "articles": 38, "confidence": 41, "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 0, "score_change_display": "-1"}, {"tone": "positive", "delta": 11, "label": "31 Jul 23:59", "score": 61, "height": 22, "articles": 38, "confidence": 40, "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "positive", "delta": 9, "label": "03 Aug 23:59", "score": 59, "height": 18, "articles": 38, "confidence": 32, "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -8, "score_change_display": "-2"}, {"tone": "positive", "delta": 8, "label": "05 Aug 23:59", "score": 58, "height": 16, "articles": 39, "confidence": 28, "short_label": "05 Aug", "collected_at": "2026-08-05T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -4, "score_change_display": "-1"}, {"tone": "neutral", "delta": 6, "label": "07 Aug 23:59", "score": 56, "height": 12, "articles": 40, "confidence": 29, "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 1, "score_change_display": "-2"}, {"tone": "neutral", "delta": 5, "label": "08 Aug 23:59", "score": 55, "height": 10, "articles": 40, "confidence": 26, "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1"}, {"tone": "positive", "delta": 9, "label": "10 Aug 23:59", "score": 59, "height": 18, "articles": 46, "confidence": 37, "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score_change": 4, "reconstructed": true, "score_version": "evidence-v11", "article_change": 6, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 11, "score_change_display": "+4"}, {"tone": "positive", "delta": 8, "label": "11 Aug 23:59", "score": 58, "height": 16, "articles": 49, "confidence": 35, "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "-1"}, {"tone": "positive", "delta": 11, "label": "12 Aug 23:59", "score": 61, "height": 22, "articles": 54, "confidence": 43, "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score_change": 3, "reconstructed": true, "score_version": "evidence-v11", "article_change": 5, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 8, "score_change_display": "+3"}, {"tone": "positive", "delta": 9, "label": "14 Aug 23:59", "score": 59, "height": 18, "articles": 53, "confidence": 36, "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -7, "score_change_display": "-2"}, {"tone": "neutral", "delta": 7, "label": "17 Aug 23:59", "score": 57, "height": 14, "articles": 52, "confidence": 30, "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-2"}, {"tone": "neutral", "delta": 6, "label": "19 Aug 23:59", "score": 56, "height": 12, "articles": 49, "confidence": 27, "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1"}, {"tone": "neutral", "delta": 5, "label": "21 Aug 23:59", "score": 55, "height": 10, "articles": 49, "confidence": 24, "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1"}, {"tone": "neutral", "delta": 4, "label": "22 Aug 23:59", "score": 54, "height": 8, "articles": 42, "confidence": 26, "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -7, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 2, "score_change_display": "-1"}, {"tone": "neutral", "delta": 6, "label": "23 Aug 23:59", "score": 56, "height": 12, "articles": 38, "confidence": 29, "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score_change": 2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -4, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 3, "score_change_display": "+2"}, {"tone": "neutral", "delta": 2, "label": "30 Aug 23:59", "score": 52, "height": 4, "articles": 32, "confidence": 19, "short_label": "30 Aug", "collected_at": "2026-08-30T23:59:59.999999+00:00", "score_change": -4, "reconstructed": true, "score_version": "evidence-v11", "article_change": -6, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -10, "score_change_display": "-4"}, {"tone": "neutral", "delta": 2, "label": "31 Aug 23:59", "score": 52, "height": 4, "articles": 33, "confidence": 18, "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "01 Sep 23:59", "score": 51, "height": 4, "articles": 35, "confidence": 18, "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "-1"}, {"tone": "neutral", "delta": 1, "label": "02 Sep 23:59", "score": 51, "height": 4, "articles": 34, "confidence": 17, "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "04 Sep 23:59", "score": 51, "height": 4, "articles": 34, "confidence": 17, "short_label": "04 Sep", "collected_at": "2026-09-04T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "+0"}, {"tone": "neutral", "delta": 3, "label": "09 Sep 23:59", "score": 53, "height": 6, "articles": 28, "confidence": 31, "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score_change": 2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -6, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 14, "score_change_display": "+2"}, {"tone": "neutral", "delta": 2, "label": "11 Sep 23:59", "score": 52, "height": 4, "articles": 20, "confidence": 25, "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -8, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-1"}, {"tone": "neutral", "delta": 1, "label": "15 Sep 23:59", "score": 51, "height": 4, "articles": 22, "confidence": 19, "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-1"}, {"tone": "neutral", "delta": 2, "label": "17 Sep 23:59", "score": 52, "height": 4, "articles": 24, "confidence": 27, "short_label": "17 Sep", "collected_at": "2026-09-17T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 8, "score_change_display": "+1"}, {"tone": "neutral", "delta": 1, "label": "18 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 25, "short_label": "18 Sep", "collected_at": "2026-09-18T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "-1"}, {"tone": "neutral", "delta": 1, "label": "19 Sep 23:59", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "19 Sep", "collected_at": "2026-09-19T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "22 Sep 23:59", "score": 51, "height": 4, "articles": 20, "confidence": 20, "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": -5, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "23 Sep 23:59", "score": 51, "height": 4, "articles": 21, "confidence": 19, "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "24 Sep 23:59", "score": 51, "height": 4, "articles": 22, "confidence": 18, "short_label": "24 Sep", "collected_at": "2026-09-24T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "25 Sep 23:59", "score": 51, "height": 4, "articles": 23, "confidence": 18, "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "27 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 24, "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 6, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "28 Sep 14:54", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "28 Sep", "collected_at": "2026-09-28T14:54:15.628731+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v11", "live_version": "evidence-v11", "comparable_to_live": true, "reconstructed": true, "observations": 52, "span_label": "96 days", "first_score": 50, "latest_score": 51, "net_change": 1, "net_change_display": "+1", "direction": "Broadly stable", "high_score": 65, "low_score": 50, "latest_confidence": 23, "confidence_change": -2, "latest_articles": 25, "article_change": 20, "latest_label": "28 Sep 14:54", "latest_evidence_label": "Provisional", "chart_rows": [{"tone": "neutral", "delta": 0, "label": "24 Jun 23:59", "score": 50, "height": 4, "articles": 5, "confidence": 25, "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score_change": null, "reconstructed": true, "score_version": "evidence-v11", "article_change": null, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": null, "score_change_display": "Start", "x": 42.0, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "25 Jun 23:59", "score": 50, "height": 4, "articles": 6, "confidence": 21, "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -4, "score_change_display": "+0", "x": 60.0, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "26 Jun 23:59", "score": 50, "height": 4, "articles": 7, "confidence": 19, "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "+0", "x": 77.9, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "27 Jun 23:59", "score": 50, "height": 4, "articles": 8, "confidence": 18, "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 95.9, "y": 135.0}, {"tone": "neutral", "delta": 1, "label": "29 Jun 23:59", "score": 51, "height": 4, "articles": 11, "confidence": 27, "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 9, "score_change_display": "+1", "x": 113.8, "y": 133.2}, {"tone": "neutral", "delta": 0, "label": "01 Jul 23:59", "score": 50, "height": 4, "articles": 12, "confidence": 20, "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -7, "score_change_display": "-1", "x": 131.8, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "03 Jul 23:59", "score": 50, "height": 4, "articles": 13, "confidence": 17, "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0", "x": 149.8, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "04 Jul 23:59", "score": 50, "height": 4, "articles": 14, "confidence": 24, "short_label": "04 Jul", "collected_at": "2026-07-04T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 7, "score_change_display": "+0", "x": 167.7, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "07 Jul 23:59", "score": 50, "height": 4, "articles": 15, "confidence": 18, "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "+0", "x": 185.7, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "09 Jul 23:59", "score": 50, "height": 4, "articles": 16, "confidence": 25, "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 7, "score_change_display": "+0", "x": 203.6, "y": 135.0}, {"tone": "neutral", "delta": 0, "label": "13 Jul 23:59", "score": 50, "height": 4, "articles": 17, "confidence": 17, "short_label": "13 Jul", "collected_at": "2026-07-13T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -8, "score_change_display": "+0", "x": 221.6, "y": 135.0}, {"tone": "neutral", "delta": 1, "label": "14 Jul 23:59", "score": 51, "height": 4, "articles": 18, "confidence": 26, "short_label": "14 Jul", "collected_at": "2026-07-14T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 9, "score_change_display": "+1", "x": 239.6, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "15 Jul 23:59", "score": 51, "height": 4, "articles": 19, "confidence": 23, "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0", "x": 257.5, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "16 Jul 23:59", "score": 51, "height": 4, "articles": 21, "confidence": 20, "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0", "x": 275.5, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "20 Jul 23:59", "score": 51, "height": 4, "articles": 23, "confidence": 28, "short_label": "20 Jul", "collected_at": "2026-07-20T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 8, "score_change_display": "+0", "x": 293.5, "y": 133.2}, {"tone": "neutral", "delta": 2, "label": "22 Jul 23:59", "score": 52, "height": 4, "articles": 25, "confidence": 31, "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 3, "score_change_display": "+1", "x": 311.4, "y": 131.4}, {"tone": "positive", "delta": 14, "label": "23 Jul 23:59", "score": 64, "height": 28, "articles": 34, "confidence": 51, "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score_change": 12, "reconstructed": true, "score_version": "evidence-v11", "article_change": 9, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 20, "score_change_display": "+12", "x": 329.4, "y": 109.5}, {"tone": "positive", "delta": 15, "label": "24 Jul 23:59", "score": 65, "height": 30, "articles": 38, "confidence": 57, "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 4, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 6, "score_change_display": "+1", "x": 347.3, "y": 107.7}, {"tone": "positive", "delta": 13, "label": "27 Jul 23:59", "score": 63, "height": 26, "articles": 37, "confidence": 46, "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -11, "score_change_display": "-2", "x": 365.3, "y": 111.3}, {"tone": "positive", "delta": 12, "label": "29 Jul 23:59", "score": 62, "height": 24, "articles": 35, "confidence": 41, "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -2, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -5, "score_change_display": "-1", "x": 383.3, "y": 113.2}, {"tone": "positive", "delta": 11, "label": "30 Jul 23:59", "score": 61, "height": 22, "articles": 38, "confidence": 41, "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 0, "score_change_display": "-1", "x": 401.2, "y": 115.0}, {"tone": "positive", "delta": 11, "label": "31 Jul 23:59", "score": 61, "height": 22, "articles": 38, "confidence": 40, "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -1, "score_change_display": "+0", "x": 419.2, "y": 115.0}, {"tone": "positive", "delta": 9, "label": "03 Aug 23:59", "score": 59, "height": 18, "articles": 38, "confidence": 32, "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -8, "score_change_display": "-2", "x": 437.1, "y": 118.6}, {"tone": "positive", "delta": 8, "label": "05 Aug 23:59", "score": 58, "height": 16, "articles": 39, "confidence": 28, "short_label": "05 Aug", "collected_at": "2026-08-05T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -4, "score_change_display": "-1", "x": 455.1, "y": 120.4}, {"tone": "neutral", "delta": 6, "label": "07 Aug 23:59", "score": 56, "height": 12, "articles": 40, "confidence": 29, "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 1, "score_change_display": "-2", "x": 473.1, "y": 124.1}, {"tone": "neutral", "delta": 5, "label": "08 Aug 23:59", "score": 55, "height": 10, "articles": 40, "confidence": 26, "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1", "x": 491.0, "y": 125.9}, {"tone": "positive", "delta": 9, "label": "10 Aug 23:59", "score": 59, "height": 18, "articles": 46, "confidence": 37, "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score_change": 4, "reconstructed": true, "score_version": "evidence-v11", "article_change": 6, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 11, "score_change_display": "+4", "x": 509.0, "y": 118.6}, {"tone": "positive", "delta": 8, "label": "11 Aug 23:59", "score": 58, "height": 16, "articles": 49, "confidence": 35, "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "-1", "x": 526.9, "y": 120.4}, {"tone": "positive", "delta": 11, "label": "12 Aug 23:59", "score": 61, "height": 22, "articles": 54, "confidence": 43, "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score_change": 3, "reconstructed": true, "score_version": "evidence-v11", "article_change": 5, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": 8, "score_change_display": "+3", "x": 544.9, "y": 115.0}, {"tone": "positive", "delta": 9, "label": "14 Aug 23:59", "score": 59, "height": 18, "articles": 53, "confidence": 36, "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Measured", "evidence_status": "measured", "confidence_change": -7, "score_change_display": "-2", "x": 562.9, "y": 118.6}, {"tone": "neutral", "delta": 7, "label": "17 Aug 23:59", "score": 57, "height": 14, "articles": 52, "confidence": 30, "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score_change": -2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-2", "x": 580.8, "y": 122.3}, {"tone": "neutral", "delta": 6, "label": "19 Aug 23:59", "score": 56, "height": 12, "articles": 49, "confidence": 27, "short_label": "19 Aug", "collected_at": "2026-08-19T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -3, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1", "x": 598.8, "y": 124.1}, {"tone": "neutral", "delta": 5, "label": "21 Aug 23:59", "score": 55, "height": 10, "articles": 49, "confidence": 24, "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "-1", "x": 616.7, "y": 125.9}, {"tone": "neutral", "delta": 4, "label": "22 Aug 23:59", "score": 54, "height": 8, "articles": 42, "confidence": 26, "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -7, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 2, "score_change_display": "-1", "x": 634.7, "y": 127.7}, {"tone": "neutral", "delta": 6, "label": "23 Aug 23:59", "score": 56, "height": 12, "articles": 38, "confidence": 29, "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score_change": 2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -4, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 3, "score_change_display": "+2", "x": 652.7, "y": 124.1}, {"tone": "neutral", "delta": 2, "label": "30 Aug 23:59", "score": 52, "height": 4, "articles": 32, "confidence": 19, "short_label": "30 Aug", "collected_at": "2026-08-30T23:59:59.999999+00:00", "score_change": -4, "reconstructed": true, "score_version": "evidence-v11", "article_change": -6, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -10, "score_change_display": "-4", "x": 670.6, "y": 131.4}, {"tone": "neutral", "delta": 2, "label": "31 Aug 23:59", "score": 52, "height": 4, "articles": 33, "confidence": 18, "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 688.6, "y": 131.4}, {"tone": "neutral", "delta": 1, "label": "01 Sep 23:59", "score": 51, "height": 4, "articles": 35, "confidence": 18, "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "-1", "x": 706.5, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "02 Sep 23:59", "score": 51, "height": 4, "articles": 34, "confidence": 17, "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": -1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 724.5, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "04 Sep 23:59", "score": 51, "height": 4, "articles": 34, "confidence": 17, "short_label": "04 Sep", "collected_at": "2026-09-04T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "+0", "x": 742.5, "y": 133.2}, {"tone": "neutral", "delta": 3, "label": "09 Sep 23:59", "score": 53, "height": 6, "articles": 28, "confidence": 31, "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score_change": 2, "reconstructed": true, "score_version": "evidence-v11", "article_change": -6, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 14, "score_change_display": "+2", "x": 760.4, "y": 129.5}, {"tone": "neutral", "delta": 2, "label": "11 Sep 23:59", "score": 52, "height": 4, "articles": 20, "confidence": 25, "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": -8, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-1", "x": 778.4, "y": 131.4}, {"tone": "neutral", "delta": 1, "label": "15 Sep 23:59", "score": 51, "height": 4, "articles": 22, "confidence": 19, "short_label": "15 Sep", "collected_at": "2026-09-15T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -6, "score_change_display": "-1", "x": 796.4, "y": 133.2}, {"tone": "neutral", "delta": 2, "label": "17 Sep 23:59", "score": 52, "height": 4, "articles": 24, "confidence": 27, "short_label": "17 Sep", "collected_at": "2026-09-17T23:59:59.999999+00:00", "score_change": 1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 2, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 8, "score_change_display": "+1", "x": 814.3, "y": 131.4}, {"tone": "neutral", "delta": 1, "label": "18 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 25, "short_label": "18 Sep", "collected_at": "2026-09-18T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "-1", "x": 832.3, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "19 Sep 23:59", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "19 Sep", "collected_at": "2026-09-19T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "+0", "x": 850.2, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "22 Sep 23:59", "score": 51, "height": 4, "articles": 20, "confidence": 20, "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": -5, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0", "x": 868.2, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "23 Sep 23:59", "score": 51, "height": 4, "articles": 21, "confidence": 19, "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 886.2, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "24 Sep 23:59", "score": 51, "height": 4, "articles": 22, "confidence": 18, "short_label": "24 Sep", "collected_at": "2026-09-24T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 904.1, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "25 Sep 23:59", "score": 51, "height": 4, "articles": 23, "confidence": 18, "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "+0", "x": 922.1, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "27 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 24, "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 6, "score_change_display": "+0", "x": 940.0, "y": 133.2}, {"tone": "neutral", "delta": 1, "label": "28 Sep 14:54", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "28 Sep", "collected_at": "2026-09-28T14:54:15.628731+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0", "x": 958.0, "y": 133.2}], "chart_points": "42.0,135.0 60.0,135.0 77.9,135.0 95.9,135.0 113.8,133.2 131.8,135.0 149.8,135.0 167.7,135.0 185.7,135.0 203.6,135.0 221.6,135.0 239.6,133.2 257.5,133.2 275.5,133.2 293.5,133.2 311.4,131.4 329.4,109.5 347.3,107.7 365.3,111.3 383.3,113.2 401.2,115.0 419.2,115.0 437.1,118.6 455.1,120.4 473.1,124.1 491.0,125.9 509.0,118.6 526.9,120.4 544.9,115.0 562.9,118.6 580.8,122.3 598.8,124.1 616.7,125.9 634.7,127.7 652.7,124.1 670.6,131.4 688.6,131.4 706.5,133.2 724.5,133.2 742.5,133.2 760.4,129.5 778.4,131.4 796.4,133.2 814.3,131.4 832.3,133.2 850.2,133.2 868.2,133.2 886.2,133.2 904.1,133.2 922.1,133.2 940.0,133.2 958.0,133.2", "changes": [{"tone": "neutral", "delta": 1, "label": "28 Sep 14:54", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "28 Sep", "collected_at": "2026-09-28T14:54:15.628731+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "27 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 24, "short_label": "27 Sep", "collected_at": "2026-09-27T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 6, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "25 Sep 23:59", "score": 51, "height": 4, "articles": 23, "confidence": 18, "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": 0, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "24 Sep 23:59", "score": 51, "height": 4, "articles": 22, "confidence": 18, "short_label": "24 Sep", "collected_at": "2026-09-24T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "23 Sep 23:59", "score": 51, "height": 4, "articles": 21, "confidence": 19, "short_label": "23 Sep", "collected_at": "2026-09-23T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -1, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "22 Sep 23:59", "score": 51, "height": 4, "articles": 20, "confidence": 20, "short_label": "22 Sep", "collected_at": "2026-09-22T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": -5, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -3, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "19 Sep 23:59", "score": 51, "height": 4, "articles": 25, "confidence": 23, "short_label": "19 Sep", "collected_at": "2026-09-19T23:59:59.999999+00:00", "score_change": 0, "reconstructed": true, "score_version": "evidence-v11", "article_change": 1, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "+0"}, {"tone": "neutral", "delta": 1, "label": "18 Sep 23:59", "score": 51, "height": 4, "articles": 24, "confidence": 25, "short_label": "18 Sep", "collected_at": "2026-09-18T23:59:59.999999+00:00", "score_change": -1, "reconstructed": true, "score_version": "evidence-v11", "article_change": 0, "evidence_label": "Provisional", "evidence_status": "provisional", "confidence_change": -2, "score_change_display": "-1"}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}